Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Tango Therapeutics (NASDAQ:TNGX) announced that its management team will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026 at 8:35 AM EDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tango Therapeutics (NASDAQ:TNGX) announced that its management team will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026 at 8:35 AM EDT. A live webcast and a 90-day replay will be accessible via the Investors section of the company’s website.
Details
News Market Reaction – TNGX
On Sep 1, the day this news came out, TNGX closed 2.10% below the previous close.
Data tracked by StockTitan Argus for the Sep 1 session.
Key Figures
- Conference date
- September 9, 2026
- 2026 Cantor Global Healthcare Conference
- Event time
- 8:35 AM EDT
- Scheduled fireside chat
- Replay availability
- 90 days
- Webcast replay following the presentation
Historical Context
-
Early clinical data and cash balance contrasted with a larger quarterly loss
-
Executive chair departure preceded a negative price reaction and leadership transition
-
Board appointment and commercialization focus were followed by a negative reaction
-
Upsized public offering and expected proceeds accompanied a sharp negative reaction
-
Proposed equity offering drew a positive reaction despite dilution risk
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) (“Tango Therapeutics” or the “Company”) today announced that members of the management team are scheduled to participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026 at 8:35 AM EDT.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors:
Elizabeth Hickin
ehickin@tangotx.com
Media:
1AB
Amanda Lazaro
amanda@1abmedia.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.